Open
運用創新轉譯醫學研發模式，專注於新藥臨床前至人體臨床藥效驗證開發階段的生技新藥公司。
BRIM is a virtually operating company, focusing on developing new drugs in various areas, including oncology and infectious disease. BRIM's pipeline is generated from sourcing deals both within and outside of Taiwan, with its experienced team surveying many small molecules, peptides, biologics, and platform technologies at the lead optimization stage.
BRIM is a virtually operating company, focusing on developing new drugs in various areas, including oncology and infectious disease. BRIM's pipeline is generated from sourcing deals both within and outside of Taiwan, with its experienced team surveying many small molecules, peptides, biologics, and platform technologies at the lead optimization stage.